Next Article in Journal / Special Issue
Cancer Stem Cells in Pancreatic Cancer
Previous Article in Journal
Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry
Previous Article in Special Issue
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
Cancers 2010, 2(3), 1617-1628; doi:10.3390/cancers2031617

ZEB1 in Pancreatic Cancer

Department of General and Visceral Surgery, University of Freiburg, Hugstetter Stra├če 55, 79106 Freiburg, Germany
* Author to whom correspondence should be addressed.
Received: 30 June 2010 / Revised: 16 August 2010 / Accepted: 17 August 2010 / Published: 18 August 2010
(This article belongs to the Special Issue Pancreatic Cancer)
View Full-Text   |   Download PDF [297 KB, uploaded 18 August 2010]   |   Browse Figures


Pancreatic cancer is one of the most malignant human neoplasias. On the molecular level, epithelial-mesenchymal transition (EMT) has been demonstrated to contribute to the malignant phenotype of pancreatic cancer cells. ZEB1 is a transcriptional repressor that has been identified as an inducer of EMT. A negative feedback loop between ZEB1 and microRNA-200c has been shown to regulate this EMT induction in various models. With respect to pancreatic cancer, primary effects of EMT comprise increased local and distant tumor cell dissemination. Another recently described feature of the EMT is the acquisition of cancer stem cell traits. For pancreatic cancer cells, antagonism between ZEB1 and stemness-inhibiting micro-RNAs has been demonstrated to contribute to this process, providing experimental support for the migrating cancer stem cell (MCSC) hypothesis. ZEB1 has also been shown to be associated with drug resistance of pancreatic cancer cells. This article reviews the biological functions of ZEB1 with a focus on pancreatic cancer.
Keywords: pancreatic cancer; ZEB1; EMT; MCSC pancreatic cancer; ZEB1; EMT; MCSC
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Wellner, U.; Brabletz, T.; Keck, T. ZEB1 in Pancreatic Cancer. Cancers 2010, 2, 1617-1628.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert